Allena Pharmaceuticals Inc expected to post a loss of 14  cents a share - Earnings Preview

Allena Pharmaceuticals

06/05/2022 12:43

* Allena Pharmaceuticals Inc  ALNA.OQ   ALNA.O  is expected
to show no change in quarterly revenue when it reports 
results on May 9 (estimated). 
    * ​Refinitiv's mean analyst estimate for Allena
Pharmaceuticals
Inc is for a loss of 14 cents per share. For the same quarter
last year, the company reported a loss of 21 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Allena
Pharmaceuticals Inc is $4​, above​ its last closing price
of $0.11. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.17       -0.16      -0.11     Beat    33.3
 Sep. 30 2021  -0.19       -0.18      -0.17     Beat    8.1
 Jun. 30 2021  -0.21       -0.21      -0.24     Missed  -14.3​
 Mar. 31 2021  -0.22       -0.23      -0.21     Beat    7.7
 ​​Dec.        -0.19       -0.19      -0.24     Missed  -24.4
 31 2020                                                
 Sep. 30 2020  -0.21       -0.21      -0.22     Missed  -3.4​
 Jun. 30 2020  -0.27       -0.30      -0.26     Beat    13.2
 Mar. 31 2020  -0.43       -0.45      -0.31     Beat    31.1
 This summary was machine generated May 6 at 11:43 GMT.  All
figures in US dollars  unless otherwise stated